Imiquimod和Resiquimod在皮肤科的应用

Application of Imiquimod and Resiquimod in Dermatology

下载PDF

导出

摘要新型小分子免疫反应调节剂Imiquimod(R-837)和Resiquimod(R-838)结构相似,具有抗病毒和抗肿瘤活性,可用作B淋巴细胞活化剂和免疫佐剂,在皮肤科广泛应用于治疗病毒性皮肤病及各种良恶性肿瘤。 Imiquimod （ R-837 ） and Resiquimod （ R-838 ）, two novel small-molecular-weight immune response modifiers, have similar structure. They have anti-virus and anti-tumor activities and can be used as B lymphocyte activators and adjuvants. They are widely used in dermatology to treat virus dermatoses and cutaneous benign or malignant tumors.

作者许可见刘跃华

机构地区中国医学科学院中国协和医科大学北京协和医院皮肤科

出处《中国医学科学院学报》 CAS CSCD 北大核心 2006年第3期445-447,共3页 Acta Academiae Medicinae Sinicae

关键词 IMIQUIMOD RESIQUIMOD 免疫反应调节剂免疫佐剂 Imiquimod Resiquimod immune response modifiers adjuvants

分类号 R751.05 [医药卫生—皮肤病学与性病学]

引文网络
相关文献

参考文献21

1Hemmi H,Kaisho T,Takeuchi O,et al.Small anti-viral com-pounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.Immunol,2002,3 (2):196-200.
2Dockrell DH,Kinghorn GR.Imiquimod and resiquimod as novel immunomodulators.J Antimicrob Chemother,2001,48(6):751-755.
3Gibson SJ,Lindh JM,Riter TR,et al.Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists,imiquimod and resiquimod.Immunol,2002,218 (1-2):74-86.
4Tomai MA,Imbertson LM,Stanczak TL,et al.The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes.Cell Immunol,2000,203 (1):55-65.
5Bishop GA,Ramirez LM,Baccam M,et al.The immune response modifier resiquimod mimics CD40-induced B cell activation.Cell Immunol,2001,208(1):9-17.
6Schon MP,Schon M.Immune modulation and apoptosis induction:two sides of the antitumoral activity of imiquimod.Apoptosis,2004,9(3):291-298.
7Schon M,Bong AB,Drewniok C,et al.Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.Cancer Inst,2003,95 (15):1138-1149.
8Thomsen LL,Topley P,Daly MG,et al.Imiquimod and resiquimod in a mouse model:adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery.Vaccine,2004,22(13-14):1799-1809.
9Otero M,Calarota SA,Felber B,et al.Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.Vaccine,2004,22 (13-14):1782-1790.
10Burns RP Jr,Ferbel B,Tomai M,et al.The imidazoquinolines,imiquimod and R-848,induce functional,but not phenotypic,maturation of human epidermal Langerhans'cells.Immunol,2000,94(1):13-23.

1王风,常江平.Imiquimod治疗9例外生殖器尖锐湿疣的临床报告[J].现代泌尿外科杂志,2005,10(5):282-283.
2关旭俊.生殖器疣治疗药——Imiquimod[J].国外新药介绍,2000(3):10-11.
3李美洲,李艳华,高顺强.皮肤肿物切除术217例观察[J].中国麻风皮肤病杂志,2006,22(8):635-635.
4倪均,张谊芝.咪喹莫特乳膏预防尖锐湿疣复发随机对照临床观察[J].中国麻风皮肤病杂志,2007,23(1):81-81. 被引量：5
5王俊杰,杨军,谢卫红,梁洁.5%咪喹莫特预防尖锐湿疣复发的临床疗效观察[J].临床皮肤科杂志,2005,34(6):404-404. 被引量：22
6冯小舸,杨建生.咪喹莫特乳膏治疗尖锐湿疣疗效观察[J].贵阳医学院学报,2005,30(3):261-262. 被引量：2
7史广伟.明欣利迪(5%咪喹莫特)乳膏治疗复发性尖锐湿疣临床观察[J].中国性科学,2007,16(6):24-25. 被引量：1
8李志红,孙鹤春,姜洪起.微波联合5%咪喹莫特乳膏治疗复发性尖锐湿疣35例临床观察[J].中国麻风皮肤病杂志,2006,22(5):368-368. 被引量：4
9孙祺琳,陈向东.咪喹莫特在真皮色素性皮肤病治疗中的作用[J].中国美容医学,2009,18(6):882-883. 被引量：2
10Xiao-hong MAO,Jian-you WANG,Jian-liang YAN.Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients:clinical evaluation on the efficacy and safety[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2012,13(9):745-750. 被引量：3

中国医学科学院学报

2006年第3期

浏览历史

内容加载中请稍等...

Imiquimod和Resiquimod在皮肤科的应用

参考文献21

相关作者

相关机构

相关主题

浏览历史